The artificial-liver blood-purification system can effectively improve hypercytokinemia for COVID-19

Jing Guo, He Xia, Shuting Wang, Liang Yu, Huafen Zhang, Jun Chen, Ding Shi, Yanfei Chen, Yan Zhang, Xiaowei Xu, Kaijin Xu, Jifang Sheng, Yunqing Qiu & Lanjuan Li
Since December 2019, the outbreak of Coronary Virus Disease 2019 (COVID-19) occurred in Wuhan, and rapidly spread across the country, and the world. As the number of diagnoses and deaths continues to rise, this has become the focus of international public health. COVID-19 is highly contagious, and there is no effective treatment. New treatment strategies are urgently needed to improve the treatment success rate of severe and critically ill patients. Increasing evidence has shown that...
32 views reported since publication in 2020.

These counts follow the COUNTER Code of Practice, meaning that Internet robots and repeats within a certain time frame are excluded.
What does this mean?